Embecta Corp. Faces Securities Class Action Lawsuit

Embecta Corp. (NASDAQ: EMBC) is facing a securities class action lawsuit that aims to represent investors who purchased or acquired Embecta common stock between November 25, 2025, and May 4, 2026.

The lawsuit alleges that Embecta and certain of its officers and directors violated federal securities laws by failing to disclose material risks related to the company's pen needle revenue. The plaintiffs claim the company issued misleading statements regarding its true business condition.

Specifically, the complaint contends that the company did not timely disclose significant risks associated with its pen needle products' supply chain and manufacturing. These undisclosed issues are alleged to have ultimately impacted the company's second-quarter financial results.

Attorneys for the investors assert that Embecta failed to provide adequate information to the investing public regarding prevailing market conditions and certain operational challenges within the company. The lawsuit is based on the company's public statements concerning its financial performance and the subsequent stock price movements.

The class action seeks to recover damages for investors who allegedly suffered losses due to the decline in Embecta's stock value following the disclosure of these risks.